.png)
Lyme Pandemic Governance Dashboard
Lyme Pandemic Governance Dashboard by the Deep Knowledge Group, showcasing key metrics such as $1.2 trillion in total costs and $800 billion in productivity losses due to Lyme disease. The dashboard includes visualizations of average insurance coverage by country and increasing health expenditures per capita, highlighting the global financial impact. A Lyme Disease Pathway is prominently featured, mapping the progression and treatment strategies for the disease. The Lyme Industry Universe visualization maps the network of companies and investors involved in Lyme-related research and healthcare.
$1.2trln
Total costs
$800bln
Loss of productivity
300
Lyme Treatment Centers
250
Top Precision Facilities
Average Insurance Coverage for Lyme
Summary:
-
Key Metrics: The chart highlights average insurance coverage for Lyme disease treatment across several countries, with Germany leading the coverage, followed by Sweden and Switzerland.
-
Coverage Comparison: Middle-ranked countries include the USA, France, and the UK, showcasing moderate levels of insurance support for Lyme treatment.
-
Lower Coverage: Countries such as Canada, the Netherlands, Italy, and Australia show lower insurance coverage percentages for Lyme disease.
Lyme Governance Overview
Summary:
-
Key Metrics: The Lyme Governance Overview presents insights on global Lyme cases reaching 750,000, with 45% funding allocation and research efforts spanning over 70 countries.
-
Cost Overview: The healthcare and indirect costs related to Lyme disease are broken down by country, with the USA, Germany, and France having the highest expenditures.
-
Spending Distribution: In 2023, healthcare costs dominate Lyme disease governance spending, constituting 40% of the total allocation.
.png)
